Stamford Pharmaceuticals

IN THE PRESS

Lone Star Bio

Stamford Pharmaceuticals Inc Announces the First Patient to Be Treated with SP-002 in Combination with Erivedge® in a Phase 2 Study in Locally Advanced BCC Subjects

April 11, 2024

·

6 min read

JOBS